Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Find out what happened in the markets today – and why you should care – with the free Daily Brief newsletter. Dr Lal Path Labs is tapping into the increasing health awareness among consumers, ...

Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is ...

(Reuters) – India’s Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher. The company’s ...

New Delhi: India's Dr Lal Path Labs reported a 19per cent jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3per cent higher.

Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 23,919.47 Crore) operating in Hospitals & Allied Services sector. Dr. Lal Pathlabs Ltd. key ...

Dr Lal Pathlabs, India’s largest diagnostic chain, posted a 19.3 per cent rise in profit after tax to Rs 98 crore for Q3FY25 on a 10.7 per cent rise in revenue to Rs 597 crore. The Ebitda grew by 9.6 ...

News for Dr. Lal Pathlabs Ltd. Dr Lal PathLabs Q3 Profit Rises 19% to Rs 98 cr Dr Lal PathLabs reports a 19% rise in profit after tax for the third quarter ended December 31, 2024, reaching Rs 98 ...

Shares of diagnostics companies led by Vijaya Diagnostics Ltd. and Dr. Lal Path Labs Ltd. buzzed in early trade on Monday as concerns mounted over the HMPV outbreak in China and reports of the first ...

Dr Lal PathLabs reports a 19% rise in profit after tax for the third quarter ended December 31, 2024, reaching Rs 98 crore. Revenue also increased to Rs 597 crore. New Delhi, Jan 30 (PTI) Dr Lal ...